Tristel PLC on Monday announced the appointment of Matthew Sassone as chief executive officer, effective from September 2.
The Newmarket, England-based maker of infection prevention products said Sassone will replace its founder, Paul Swinney, who has been CEO for 30 years.
Tristel said Swinney announced his plans to retire last year. He will, however, stay ‘for a suitable period to allow for a successful transition of leadership’.
Sassone joins Tristel from three years as senior vice president of marketing at Irvine, California-based medical technology company Masimo Corp. He was previously CEO of London-based LiDCO Group PLC from August 2015 until February 2021, when Masimo acquired LiDCO for £31 million.
‘We have become the global market leader in manual high-level disinfection of medical devices and now have a foothold in the world’s largest healthcare market,’ said outgoing CEO Swinney. ‘Matt’s first-hand experience of North America will propel us to great success there.’
Sassone commented: ‘Tristel has a well-earned reputation for innovation and excellence in infection prevention, and I look forward to leading this exceptional business.
‘My focus will be on building on Paul Swinney’s strong foundation, capturing global opportunities, and expanding our presence in key markets like North America. Together, we will continue to drive growth and deliver exceptional value to our customers and stakeholders.’
Shares in Tristel were untraded on Monday morning in London. They last at 430.00 pence on Friday afternoon.
Copyright 2024 Alliance News Ltd. All Rights Reserved.
